4.5 Article

Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: A novel ALK fusion gene?

Journal

CANCER SCIENCE
Volume 103, Issue 2, Pages 390-392

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1349-7006.2011.02136.x

Keywords

-

Categories

Funding

  1. Grants-in-Aid for Scientific Research [22680063] Funding Source: KAKEN

Ask authors/readers for more resources

Echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase (EML4ALK) and kinesin family member 5B (KIF5B)ALK are newly identified transforming fusion oncogenes causing non-small-cell lung cancers. These molecular abnormalities have become detectable using not only molecular biological methods, but also highly sensitive immunohistochemistry. During the immunohistochemical study of ALK expression in adenocarcinoma of the lung, we unexpectedly discovered that a small bronchioloalveolar carcinoma (BAC) showed strong ALK immunoreactivity. However, FISH studies failed to reveal EML4ALK and KIF5BALK fusion genes in this BAC. These findings suggest the possibility that a novel or unknown ALK fusion gene plays a crucial role in BAC development. (Cancer Sci 2012; 103: 390392)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available